{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:17:55Z","timestamp":1780503475803,"version":"3.54.1"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Evidence from clinical trials and observational studies on the association between thiazide diuretics and colorectal cancer risk is conflicting. We aimed to determine whether thiazide diuretics are associated with an increased colorectal cancer risk compared with dihydropyridine calcium channel blockers (dCCBs). A population-based, new-user cohort was assembled using the UK Clinical Practice Research Datalink. Between 1990\u20132018, we compared thiazide diuretic initiators with dCCB initiators and estimated hazard ratios (HR) with 95% confidence intervals (CIs) of colorectal cancer using Cox proportional hazard models. Models were weighted using standardized morbidity ratio weights generated from calendar time-specific propensity scores. The cohort included 377,760 thiazide diuretic initiators and 364,300 dCCB initiators, generating 3,619,883 person-years of follow-up. Compared with dCCBs, thiazide diuretics were not associated with colorectal cancer (weighted HR\u00a0= 0.97, 95% CI: 0.90, 1.04). Secondary analyses yielded similar results, although an increased risk was observed among patients with inflammatory bowel disease (weighted HR\u00a0= 2.45, 95% CI: 1.13, 5.35) and potentially polyps (weighted HR\u00a0= 1.46, 95% CI: 0.93, 2.30). Compared with dCCBs, thiazide diuretics were not associated with an overall increased colorectal cancer risk. While these findings provide some reassurance, research is needed to corroborate the elevated risks observed among patients with inflammatory bowel disease and history of polyps.<\/jats:p>","DOI":"10.1093\/aje\/kwad171","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T13:09:37Z","timestamp":1691586577000},"page":"47-57","source":"Crossref","is-referenced-by-count":2,"title":["Thiazide Diuretics and Risk of Colorectal Cancer: A Population-Based Cohort Study"],"prefix":"10.1093","volume":"193","author":[{"given":"Julie","family":"Rouette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily G","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tibor","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Matok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Brophy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"issue":"17","key":"2024010814545051600_ref1","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2015.13766","article-title":"Trends in prescription drug use among adults in the United States from 1999\u20132012","volume":"314","author":"Kantor","year":"2015","journal-title":"JAMA."},{"issue":"5","key":"2024010814545051600_ref2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cjca.2022.01.029","article-title":"Epidemiology of resistant hypertension in Canada","volume":"38","author":"Leung","year":"2022","journal-title":"Can J Cardiol."},{"issue":"6","key":"2024010814545051600_ref3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057510","article-title":"Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study","volume":"12","author":"Rouette","year":"2022","journal-title":"BMJ Open."},{"issue":"2","key":"2024010814545051600_ref4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.21618","article-title":"Comparison of cardiovascular events among users of different classes of antihypertension medications: a systematic review and network meta-analysis","volume":"3","author":"Wei","year":"2020","journal-title":"JAMA Netw Open."},{"issue":"10211","key":"2024010814545051600_ref5","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/S0140-6736(19)32317-7","article-title":"Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis","volume":"394","author":"Suchard","year":"2019","journal-title":"Lancet."},{"key":"2024010814545051600_ref6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ."},{"issue":"5","key":"2024010814545051600_ref7","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1021\/mp900163d","article-title":"Computational models for drug inhibition of the human apical sodium-dependent bile acid transporter","volume":"6","author":"Zheng","year":"2009","journal-title":"Mol Pharm."},{"key":"2024010814545051600_ref8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1477-7819-12-164","article-title":"Secondary bile acids: an underrecognized cause of colon cancer","volume":"12","author":"Ajouz","year":"2014","journal-title":"World J Surg Oncol."},{"issue":"11","key":"2024010814545051600_ref9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/pds.1656","article-title":"Long-term use of antihypertensive drugs and risk of cancer","volume":"17","author":"Assimes","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"2","key":"2024010814545051600_ref10","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djt374","article-title":"Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk","volume":"106","author":"Makar","year":"2014","journal-title":"J Natl Cancer Inst."},{"issue":"11","key":"2024010814545051600_ref11","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1158\/1055-9965.EPI-08-0095","article-title":"Cardiovascular medication use and risk for colorectal cancer","volume":"17","author":"Boudreau","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"6","key":"2024010814545051600_ref12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/EDE.0000000000001065","article-title":"Renin-angiotensin-aldosterone system-based antihypertensive agents and the risk of colorectal cancer among Medicare beneficiaries","volume":"30","author":"Htoo","year":"2019","journal-title":"Epidemiology."},{"issue":"3","key":"2024010814545051600_ref13","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/HYPERTENSIONAHA.120.15317","article-title":"ACE (angiotensin-converting enzyme) inhibitors\/angiotensin receptor blockers are associated with lower colorectal cancer risk: a territory-wide study with propensity score analysis","volume":"76","author":"Cheung","year":"2020","journal-title":"Hypertension."},{"issue":"5","key":"2024010814545051600_ref14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-20-1401","article-title":"Associations of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with colorectal cancer risk in the Women's Health Initiative","volume":"30","author":"Brasky","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"issue":"12","key":"2024010814545051600_ref15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050893","article-title":"Long-term use of angiotensin receptor blockers and the risk of cancer","volume":"7","author":"Azoulay","year":"2012","journal-title":"PloS One."},{"issue":"6","key":"2024010814545051600_ref16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.jhh.1001192","article-title":"Long-term diuretic therapy in patients with coronary disease: increased colon cancer-related mortality over a 5-year follow-up","volume":"15","author":"Tenenbaum","year":"2001","journal-title":"J Hum Hypertens."},{"issue":"17","key":"2024010814545051600_ref17","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/jama.2016.16435","article-title":"Confounding by indication in clinical research","volume":"316","author":"Kyriacou","year":"2016","journal-title":"JAMA."},{"issue":"9","key":"2024010814545051600_ref18","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/aje\/kwg231","article-title":"Evaluating medication effects outside of clinical trials: new-user designs","volume":"158","author":"Ray","year":"2003","journal-title":"Am J Epidemiol."},{"issue":"4","key":"2024010814545051600_ref19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1470-2045(21)00033-4","article-title":"Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis","volume":"22","author":"Copland","year":"2021","journal-title":"Lancet Oncol."},{"issue":"9","key":"2024010814545051600_ref20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003389","article-title":"Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD)","volume":"3","author":"Bhaskaran","year":"2013","journal-title":"BMJ Open."},{"issue":"3","key":"2024010814545051600_ref21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol."},{"issue":"2","key":"2024010814545051600_ref22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/pds.3374","article-title":"Cancer recording and mortality in the General Practice Research Database and linked cancer registries","volume":"22","author":"Boggon","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"5","key":"2024010814545051600_ref23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.canep.2012.05.013","article-title":"Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study","volume":"36","author":"Dregan","year":"2012","journal-title":"Cancer Epidemiol."},{"key":"2024010814545051600_ref24","first-page":"694","article-title":"Treating mild hypertension","volume":"298","author":"Swales","year":"1989","journal-title":"BMJ."},{"issue":"6883","key":"2024010814545051600_ref25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/bmj.306.6883.983","article-title":"Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society","volume":"306","author":"Sever","year":"1993","journal-title":"BMJ."},{"issue":"9","key":"2024010814545051600_ref26","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/sj.jhh.1000917","article-title":"Guidelines for management of hypertension: report of the third working party of the British Hypertension Society","volume":"13","author":"Ramsay","year":"1999","journal-title":"J Hum Hypertens."},{"key":"2024010814545051600_ref27","volume-title":"Hypertension: Management in Adults in Primary Care: Pharmacological Update","author":"National Collaborating Centre for Chronic Conditions","year":"2006"},{"key":"2024010814545051600_ref28","volume-title":"Hypertension\u2014Management of Hypertension in Adults in Primary Care","author":"National Institute for Clinical Excellence","year":"2004"},{"key":"2024010814545051600_ref29","volume-title":"Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34 (Internet)","author":"National Institute for Health and Clinical Excellence","year":"2011"},{"key":"2024010814545051600_ref30","volume-title":"Hypertension in Adults: Diagnosis and Management","author":"National London, UKfor Health and Care Excellence","year":"2019"},{"issue":"1","key":"2024010814545051600_ref31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009147","article-title":"Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD)","volume":"6","author":"Grimaldi-Bensouda","year":"2016","journal-title":"BMJ Open."},{"key":"2024010814545051600_ref32","article-title":"Effects of antihypertensive drugs use on risk and prognosis of colorectal cancer: a meta-analysis of 37 observational studies","volume":"12","author":"Deng","year":"2021","journal-title":"Front Pharmacol."},{"issue":"2","key":"2024010814545051600_ref33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJM199601113340204","article-title":"Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup","volume":"334","author":"Winawer","year":"1996","journal-title":"N Engl J Med."},{"issue":"5","key":"2024010814545051600_ref34","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/0016-5085(93)90368-M","article-title":"Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review","volume":"104","author":"Lynch","year":"1993","journal-title":"Gastroenterology."},{"issue":"21","key":"2024010814545051600_ref35","first-page":"4799","article-title":"STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer","volume":"58","author":"Resta","year":"1998","journal-title":"Cancer Res."},{"issue":"11","key":"2024010814545051600_ref36","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1002\/1097-0142(19930601)71:11<3493::AID-CNCR2820711106>3.0.CO;2-H","article-title":"Identification of hereditary nonpolyposis colorectal cancer in the general population. The 6-year experience of a population-based registry","volume":"71","author":"Ponz de Leon","year":"1993","journal-title":"Cancer."},{"issue":"6","key":"2024010814545051600_ref37","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1470-2045(18)30188-8","article-title":"Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis","volume":"19","author":"Yamada","year":"2018","journal-title":"Lancet Oncol."},{"issue":"3","key":"2024010814545051600_ref38","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/ajt.13549","article-title":"Risk of colorectal cancer after solid organ transplantation in the United States","volume":"16","author":"Safaeian","year":"2016","journal-title":"Am J Transplant."},{"issue":"6","key":"2024010814545051600_ref39","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/ije\/dys188","article-title":"Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER)","volume":"41","author":"Denaxas","year":"2012","journal-title":"Int J Epidemiol."},{"issue":"1","key":"2024010814545051600_ref40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s12885-018-4265-1","article-title":"Trends in the contemporary incidence of colorectal cancer and patient characteristics in the United Kingdom: a population-based cohort study using The Health Improvement Network","volume":"18","author":"Soriano","year":"2018","journal-title":"BMC Cancer."},{"key":"2024010814545051600_ref41","article-title":"Alternative approaches for confounding adjustment in observational studies using weighting based on the propensity score: a primer for practitioners","volume":"367","author":"Desai","year":"2019","journal-title":"BMJ."},{"issue":"25","key":"2024010814545051600_ref42","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med."},{"issue":"15","key":"2024010814545051600_ref43","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/sim.3618","article-title":"Imputing missing covariate values for the Cox model","volume":"28","author":"White","year":"2009","journal-title":"Stat Med."},{"issue":"1","key":"2024010814545051600_ref44","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1186\/s12885-018-4786-7","article-title":"A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK","volume":"18","author":"White","year":"2018","journal-title":"BMC Cancer."},{"issue":"5","key":"2024010814545051600_ref45","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.annonc.2020.02.012","article-title":"Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019","volume":"31","author":"Bosetti","year":"2020","journal-title":"Ann Oncol."},{"issue":"29","key":"2024010814545051600_ref46","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.3748\/wjg.v20.i29.9872","article-title":"Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis","volume":"20","author":"Kim","year":"2014","journal-title":"World J Gastroenterol."},{"issue":"3","key":"2024010814545051600_ref47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-2005-916274","article-title":"Colorectal cancer: epidemiology, risk factors, and health services","volume":"18","author":"Amersi","year":"2005","journal-title":"Clin Colon Rectal Surg."},{"issue":"11","key":"2024010814545051600_ref48","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/s41416-022-01975-4","article-title":"Long-term use of antihypertensive medications, hypertension and colorectal cancer risk and mortality: a prospective cohort study","volume":"127","author":"Zhang","year":"2022","journal-title":"Br J Cancer."},{"issue":"4","key":"2024010814545051600_ref49","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmaco-epidemiology","volume":"167","author":"Suissa","year":"2008","journal-title":"Am J Epidemiol."},{"issue":"6","key":"2024010814545051600_ref50","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10552-022-01570-1","article-title":"Anti-hypertensive medications and risk of colorectal cancer: a systematic review and meta-analysis","volume":"33","author":"Qi","year":"2022","journal-title":"Cancer Causes Control."},{"issue":"10","key":"2024010814545051600_ref51","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s10552-021-01472-8","article-title":"Medication use and risk of proximal colon cancer: a systematic review of prospective studies with narrative synthesis and meta-analysis","volume":"32","author":"Harewood","year":"2021","journal-title":"Cancer Causes Control."},{"issue":"10304","key":"2024010814545051600_ref52","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","journal-title":"Lancet."},{"issue":"4","key":"2024010814545051600_ref53","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/HJH.0b013e3282f3ef5e","article-title":"Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials","volume":"26","author":"Coleman","year":"2008","journal-title":"J Hypertens."},{"issue":"1","key":"2024010814545051600_ref54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1470-2045(10)70260-6","article-title":"Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials","volume":"12","author":"Bangalore","year":"2011","journal-title":"Lancet Oncol."},{"key":"2024010814545051600_ref55","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"Levesque","year":"2010","journal-title":"BMJ."},{"issue":"658","key":"2024010814545051600_ref56","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.3399\/bjgp17X690461","article-title":"Trends in the diagnosis and management of hypertension: repeated primary care survey in South West England","volume":"67","author":"Mejzner","year":"2017","journal-title":"Br J Gen Pract."},{"key":"2024010814545051600_ref57","article-title":"Hypertension in adults: summary of updated NICE guidance","volume":"367","author":"Boffa","year":"2019","journal-title":"BMJ."}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/aje\/advance-article-pdf\/doi\/10.1093\/aje\/kwad171\/53706860\/kwad171.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/193\/1\/47\/55024964\/kwad171.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/193\/1\/47\/55024964\/kwad171.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T14:55:31Z","timestamp":1704725731000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article\/193\/1\/47\/7241427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,8,11]]},"published-print":{"date-parts":[[2024,1,8]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwad171","relation":{},"ISSN":["0002-9262","1476-6256"],"issn-type":[{"value":"0002-9262","type":"print"},{"value":"1476-6256","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1]]},"published":{"date-parts":[[2023,8,11]]}}}